Treatment with Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) Results in Durable Remissions in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphomas of Germinal Center and Non-Germinal Center Origin, "Double Hit" Diffuse Large B Cell Lymphomas, and Transformed Follicular to Diffuse Large B Cell Lymphomas

Stephen J Schuster,Jakub Svoboda,Sunita Dwivedy Nasta,Elise A Chong,Nicole Winchell,Daniel J Landsburg,David L Porter,Anthony R Mato,Honore T Strauser,April M Schrank-Hacker,Mariusz A Wasik,Simon Francis Lacey,Jan Joseph Melenhorst,Anne Chew,Jens Hasskarl,Katherine T Marcucci,Bruce L Levine,Carl H June

doi:10.1182/blood.v128.22.3026.3026

Treatment with Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) Results in Durable Remissions in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphomas of Germinal Center and Non-Germinal Center Origin, "Double Hit" Diffuse Large B Cell Lymphomas, and Transformed Follicular to Diffuse Large B Cell Lymphomas

Stephen J Schuster, Jakub Svoboda + Show 16 more

https://doi.org/10.1182/blood.v128.22.3026.3026

Copy DOI

Export

Save

Cite

Journal: Blood	Publication Date: Dec 2, 2016
Citations: 17

Affiliation: Cheyney University of Pennsylvania, University of Pennsylvania, Novartis (Switzerland)

#Germinal Center Diffuse Large B Cell Lymphoma #Double Hit" Diffuse Large B Cell Lymphoma #Diffuse Large B Cell Lymphoma #Research Funding #Non-germinal Center Diffuse Large B Cell Lymphoma #CTL019 Cells #CTL019 Cell #Non-germinal Center #Germinal Center #Equity Ownership

Abstract
Full-Text
Similar Papers

Abstract

Listen

Treatment with Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) Results in Durable Remissions in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphomas of Germinal Center and Non-Germinal Center Origin, "Double Hit" Diffuse Large B Cell Lymphomas, and Transformed Follicular to Diffuse Large B Cell Lymphomas

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime